DIG
JSPRW icon

DeepCurrents Investment Group’s Japer Therapeutics Warrants JSPRW Stock Holding History

DeepCurrents Investment Group’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-29,136
Closed -$36.5K – 175
2020
Q3 		$20K Buy
+29,136
New +$29.5K ﹤0.01% 109

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

DeepCurrents Investment Group's JSPRW Position: Q4 2020 in Review

DeepCurrents Investment Group sold out of Japer Therapeutics Warrants (JSPRW) in Q4 2020, closing a stake of 29,136 shares — an estimated $36.5K sold.

DeepCurrents Investment Group first reported a position in JSPRW in Q3 2020 and held it in 1 quarter. The position peaked at $20K in Q3 2020. 35 funds tracked by Wall St. Rank hold JSPRW as of Q4 2020.

  • DeepCurrents Investment Group reported no remaining Japer Therapeutics Warrants position as of Q4 2020 after selling out during the quarter.
  • DeepCurrents Investment Group sold 29,136 Japer Therapeutics Warrants shares in Q4 2020, an estimated $36.5K.
  • DeepCurrents Investment Group first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 1 quarter.
  • DeepCurrents Investment Group's Japer Therapeutics Warrants position peaked at $20K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q4 2020.

Based on DeepCurrents Investment Group's 13F filing for Q4 2020, filed 16 Feb 2021.